Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
132
days
Real-world assessment of effectiveness and safety of candesartan in migraine prevention: Results of the French FHU InovPain registry
AuthorsS. Ferrao-Malheiro; R. Fabre; M. Lanteri-Minet
AffiliationsPain Department, UR2CA-PIN, FHU InovPain, CHU de Nice, Côte d’Azur University, Nice, France; Public Health Department, FHU InovPain, UR2CA – RESPECT, CHU de Nice, Côte Azur University, Nice, France; Inserm U1107 Migraine and Trigeminal Pain, Auvergne University, Clermont-Ferrand, France
173
days
Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study
AuthorsR. Demeret; D. Vieles Marais; E. Treiner; B. Acket; V. Fabry; T. Levade; L. Nogueira; J.-C. Pages; P. Cintas
AffiliationsService de neurologie, CHU de Toulouse-Purpan, place du Docteur Baylac, 31300 Toulouse, France; Service de biologie cellulaire et cytologie, CHU de Toulouse-Purpan, place du Docteur Baylac, 31300 Toulouse, France; Laboratoire d’immunologie, institut fédératif de biologie, CHU de Toulouse-Purpan, place du Docteur Baylac, 31300 Toulouse, France; Pôle neurosciences, centre SLA, CHU de Toulouse-Purpan, place du Docteur Baylac, 31300 Toulouse, France; Laboratoire de biochimie, institut fédératif de biologie, CHU de Toulouse-Purpan, place du Docteur Baylac, 31300 Toulouse, France; Laboratoire de biologie cellulaire et cytologie, institut fédératif de Biologie, CHU de Toulouse-Purpan, place du Docteur Baylac, 31300 Toulouse, France
70
days
Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry
AuthorsC. Maisonnier; J.-P. Cottier; G. Charbonnier; A. Monaya; J. Rhein; M. Gaudron; M. Haba; N. Deschamps; A. Nasri; B. de Toffol; I.L. Maldonado
AffiliationsCHRU de Tours, Tours, France; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032 Tours, France; CHU de Besançon, Besançon, France; CHU de Cayenne Andrée Rosemon, Cayenne, French Guiana; Inserm CIC1424, Antilles, French Guiana; UA17 Santé des populations en Amazonie, Cayenne, French Guiana
249
days
Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?
AuthorsA. Marques; C. Lambert; P. Derost; C. Beal; B. Debilly; I. Rieu; F. Durif
AffiliationsDepartment of Neurology, CNRS, Pascal Institute, CHU de Clermont-Ferrand, Université Clermont-Auvergne, 63000 Clermont-Ferrand, France; Biostatistics Unit, DRCI, CHU de Clermont-Ferrand, 63000 Clermont-Ferrand, France
259
days
Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives
AuthorsA. Launay; A. Baudouin; C. Gonthier; M. Brachet; A. Matysiak; S. Vanneste; L. Taconnat
AffiliationsCentre de recherche sur la cognition et l’apprentissage (CeRCA), UMR-CNRS 7295, université de Tours, Tours, France; Centre mémoire de ressources et de recherche (CMRR), CHRU de Tours, Tours, France; Institut de psychologie, LMC2 UR 7536, université Paris-Cité, Paris, France; Laboratoire de psychologie des Pays de la Loire (LPPL UR 4638), Nantes université, 44000 Nantes, France; Institut universitaire de France, Paris, France
84
days
Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families
AuthorsH. Gharebaghian; M. Ravanbod; A. Ghasemi; A. Asghar Okhovat; S. Nafissi; A. Alavi
AffiliationsNeuromuscular Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Neurology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran; Neurology Department, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran
286
days
Current management and treatment of patients with myasthenia gravis in France: A survey of the neurologist's perspective
AuthorsP. Cintas; E. Salort-Campana; S. Demeret; T. Stanbury; B. Bouquillon; A. Nadaj-Pakleza; J. Gallard; G. Solé; S. Attarian
AffiliationsCentre de référence des maladies neuromusculaires (CRMN), CHU de Toulouse, Toulouse, France; CRMN PACA-Réunion-Rhône Alpes, FILNEMUS, CHU de La Timone, Marseille, France; Service de médecine intensive et réanimation neurologique, CRMN Nord-Est-Île-de-France, CHU de Pitié-Salpêtrière, Paris, France; Carely, Lys-les-Lannoy, France; CRMN Nord-Est-Île-de-France, ERN EURO-NMD, CHU de Strasbourg, Strasbourg, France; Neurologue libéral, Marseille, France; Service de neurologie et maladies neuromusculaires, CRMN Atlantique-Occitanie-Caraïbes, EURO-NMD, FILNEMUS, CHU de Bordeaux, Bordeaux, France; FILNEMUS, CRMN Provence-Alpes-Côte d’Azur-Réunion-Rhône Alpes, CHU de Marseille, Marseille, France
310
days
Ambulatory introduction of foslevodopa/foscarbidopa in Parkinson's disease in private practice. Case series of the first 22 patients
AuthorsC. Bonnet; V. Mesnage; F. Sacko; C. Ziz; P. Jaulent
AffiliationsNeurological Ambulance, 58, rue Albert Joly, 78000 Versailles, France; Neurological Ambulance, Neurhône, 123, Boulevard Pinel, 69500 Bron, France; Hôpital Foch, 40, rue Worth, 92150 Suresnes, France
221
days
Six-month outcomes of subcutaneous foslevodopa/foscarbidopa according to initiation setting in advanced Parkinson's disease: A retrospective cohort study
AuthorsC. Desjardins; H. de Saint Vaulry; C. Rosset; Q. Salardaine; J.-P. Brandel; G. Baille
AffiliationsDepartment of Neurology, Fondation Rothschild Hospital, Paris-Cité University, 33, rue Manin, 75019 Paris, France
74
days
Real-world utilization of acute treatments for cluster headache: Insights from the French National Open Health Data
AuthorsV. Arcani; A. Bruyat; G. Hache; A. Donnet; S. Redon
AffiliationsAix-Marseille Université, AP-HM, Hôpital de La Timone, Service Pharmacie, 264, rue Saint-Pierre, 13005 Marseille, France; Aix-Marseille Université, INSERM 1263, INRAE 1260, C2VN, Marseille, France; Aix-Marseille Université, AP-HM, Hôpital de La Timone, Centre d’Evaluation et de Traitement de la Douleur, 264, rue Saint-Pierre, 13005 Marseille, France; INSERM U-1107, CHU de Clermont-Ferrand, Clermont-Ferrand, France; FHU InovPain, Nice, France
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days